Skip to content

Validity of OptiVol alert MOMOTARO study (MOnitoring and Management of OpTiVol Alert to Reduce heart failure admissiOn)

Validity of OptiVol alert MOMOTARO study (MOnitoring and Management of OpTiVol Alert to Reduce heart failure admissiOn) - MOMOTARO study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000003351
Enrollment
200
Registered
2010-04-01
Start date
2010-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient who has organic heart disease with ICD or CRTD.

Interventions

None listed

Sponsors

Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient who has organic heart disease and requiring ICD or CRTD. Patient received ICD or CRTD.

Exclusion criteria

Exclusion criteria: 1) Patient under 20 years old. 2) Patient with moderate or severe chronic obstructive lung disease (forced expiratory volume < 1.0 L/s). 3) Patient who is received heart transplantation or is supposed to receive heart transplantation. 4) Patient with primary pulmonary hypertension. 5) Patient with dialysis. 6) Patient under one year of life expectancy. 7) Patient with pregnancy or possible pregnancy. 8) Patient in whom doctor think inadequate. 9) Patient with heart failure in enrollment.

Design outcomes

Primary

MeasureTime frame
Comparison of BNP and E/e' in OptiVol alert to that in control

Secondary

MeasureTime frame
Comparison of other data in OptiVol alert to that in control

Countries

Japan

Contacts

Public ContactNobuhiro Nishii

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Department of Cardiovascular Medicine

nnishii@md.okayama-u.ac.jp086-235-7351

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026